Pharmaceutical formulations for the sustained release of one or more active principles and therapeutic applications thereof
Abstract
The invention relates to novel, based on stable, a of a pasting a long buckled active ingredients, specifically a protein which active medicine formulation, the invention further claims the applications of said formulation, specifically application of therapeutics. Purpose of the invention claims a release of active agents to the liquid medicine formulation, the formula of the outer gastrointestinal hose, a display is a treating with a protein of the body the time, and reducing active protein blood plasma concentration top. Moreover, wherein and can be is stably, and biological is accommodating, and a biodegradable, and not of the immunity, and lower part tolerance. The invention formula based on connecting the hydrophobic group water-solubility a biodegradable polymer the lower viscosity hydrosol a of micro grains, wherein the particle non-covalence at least one active ingredient (AP) connected, and formed the gel heater object at the position injection part; the gel gelation gelling of the problem of the physiological medium's protein.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
36 members in 22 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 0350887 | France | A | |
| 2004050603 | France | W |
Members36
| Document | Office | Kind | |
|---|---|---|---|
| FR2862536A1 | France | A1 | |
| AU2004292369A1 | Australia | A1 | |
| CA2546675A1 | Canada | A1 | |
| WO2005051416A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200518775A | Taiwan Province of China | A | |
| EP1689425A1 | European Patent Office (EPO) | A1 | |
| IL175768A0 | Israel | A0 | |
| IL175768D0 | Israel | D0 | |
| KR20060130076A | Republic of Korea | A | |
| CN1886151A | China | A | |
| MXPA06005717A | Mexico | A | |
| BRPI0416779A | Brazil | A | |
| JP2007511586A | Japan | A | |
| US2007196497A1 | United States of America | A1 | |
| FR2862536B1 | France | B1 | |
| ZA200603950B | South Africa | B | |
| EP1689425B1 | European Patent Office (EPO) | B1 | |
| AT451116TThis record | Austria | T | |
| ATE451116T1 | Austria | T1 | |
| DE602004024571D1 | Germany | D1 | |
| EP1689425B8 | European Patent Office (EPO) | B8 | |
| PT1689425E | Portugal | E | |
| DK1689425T3 | Denmark | T3 | |
| SI1689425T1 | Slovenia | T1 | |
| ES2338012T3 | Spain | T3 | |
| PL1689425T3 | Poland | T3 | |
| AU2004292369B2 | Australia | B2 | |
| KR101092547B1 | Republic of Korea | B1 | |
| US8084045B2 | United States of America | B2 | |
| IL175768A | Israel | A | |
| JP4988352B2 | Japan | B2 | |
| CN1886151B | China | B | |
| CA2546675C | Canada | C | |
| CY1110612T1 | Cyprus | T1 | |
| BRPI0416779B1 | Brazil | B1 | |
| BRPI0416779B8 | Brazil | B8 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 4805846
Titles2
- German
- PHARMAZEUTISCHE FORMULIERUNGEN FÜR DIE VERZÖGERTE FREISETZUNG VON EIN ODER MEHR WIRKSTOFFEN UND IHRE THERAPEUTISCHE ANWENDUNGEN
- English
- PHARMACEUTICAL FORMULATIONS FOR THE DELAYED RELEASE OF ONE OR MORE ACTIVE AGENTS AND THEIR THERAPEUTIC APPLICATIONS
Classification
- CPC, 8
- A61K9/0024
- A61K9/08
- A61K38/2013
- A61K38/212
- A61K47/42
- A61K51/1217
- A61K47/645
- A61K38/21
- IPC, 7
- A61K38 21
- A61K9 14
- A61K38 17
- A61K38 20
- A61K47 42
- A61K47 48
- A61K51 12